Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Biologists Figured Out How to Generate New Neurons in the Adult Brain, Revolutionizing Neurodegenerative Disease Research

Recently biologists discovered how to generate new neurons in the adult brain. This is an incredible breakthrough that has enormous potential to revolutionize neurodegenerative disease research. By generating genetically-mutated mice with a unique gene that activates dormant neural stem cells, scientists were able to generate new neurons in the brain. For years, scientists have…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Recently biologists discovered how to generate new neurons in the adult brain. This is an incredible breakthrough that has enormous potential to revolutionize neurodegenerative disease research. By generating genetically-mutated mice with a unique gene that activates dormant neural stem cells, scientists were able to generate new neurons in the brain. For years, scientists have been searching for ways to promote the growth of new neurons in the brain, especially in individuals with neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This new discovery could lead to new treatments and therapies that could help to restore brain function and improve the quality of life for millions of people around the world.

Leslie Samuel, founder of Interactive Biology, gives some context for the importance of genetic trading between organisms for scientific research, and notes how the loss of nerve cells in the brain is one of the hallmarks of neurodegenerative diseases. The ability to generate new neurons in the adult brain could be a game-changer in the field of neurology.

Leslie’s Thoughts

“Anytime you have a situation where extracts from one organism can have beneficial effects on another organism, especially if that other organism is a human, I think it’s an exciting thing. In my last video I spoke about how certain cordyceps fungi can have anti-cancer effects. But it doesn’t stop there.

In fact, studies are beginning to show that some compounds that are extracted from certain species of cordyceps can help to protect neurons from damage and even promote their growth by increasing the production of nerve growth factor. This has potentially huge implications for people suffering with neurodegenerative diseases, things like Alzheimer’s disease or Parkinson’s disease, because these diseases are characterized by a loss of nerve cells in the brain.

So if we can somehow stimulate the exact opposite nerve cell growth, that could be very helpful. But it’s important to understand that we’re still relatively early in this process of studying whether this can be beneficial in therapies in the future. But regardless, it’s awesome to see the progress that’s been made so far, and it’s exciting to think about what that could mean for the future.”

Article written by Galina Mikova.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Health systems are partnering up without changing who owns the hospital

Health systems are partnering up without changing who owns the hospital

Health systems are choosing alliances over mergers, per a July McDermott Will & Schulte analysis and four July deals tracked by Becker's Hospital Review. St. Christopher's, Nemours, Jefferson and Temple signed a nonbinding alliance letter; Palomar UC San Diego Health launched July 1. Ownership stays put; governance, purchasing and outpatient investment absorb the change.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Telemedicine in eye care stops at the retinal scan unless imaging moves home

Telemedicine in eye care stops at the retinal scan unless imaging moves home

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512